title: Acute pancreatitis attributed to the use of pegylated interferon in a patient with chronic hepatitis C.
authors.forename: Veysel
authors.initials: V
authors.lastname: Tahan
authors.forename: Gulgun
authors.initials: G
authors.lastname: Tahan
authors.forename: Faysal
authors.initials: F
authors.lastname: Dane
authors.forename: Suleyman
authors.initials: S
authors.lastname: Uraz
authors.forename: Mithat
authors.initials: M
authors.lastname: Yardim
mesh_terms: D000208:Acute Disease; D000998:Antiviral Agents / Q000009:adverse effects*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D010195:Pancreatitis / Q000139:chemically induced*; D011092:Polyethylene Glycols; D011994:Recombinant Proteins
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C417083:peginterferon alfa-2b